17:39 EST Casi Pharmaceuticals (CASI) files $200M mixed securities shelf
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CASI:
- CASI Pharmaceuticals Faces Evomela® License Termination Dispute
- Berkshire reveals stake in Domino’s, Alibaba reports mixed Q2: Morning Buzz
- CASI Pharmaceuticals’ Mixed Third-Quarter Performance in 2024
- Casi Pharmaceuticals reports Q3 EPS (55c) vs. (35c) last year
- CASI Earnings this Week: How Will it Perform?